Patients with advanced non-small cell lung cancer may have tumour biopsy replaced with a simple blood test to assess their treatment options
Patients with advanced non-small cell lung cancer (NSCLC) may soon be offered a blood test to assess their treatment options, instead of having to provide a tumour sample for analysis.








